使用引导引物评估慢性淋巴细胞白血病中IGHV突变状态的影响 - Suppr

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.

作者信息

Huet Sarah, Bouvard Anne, Ferrant Emmanuelle, Mosnier Isabelle, Chabane Kaddour, Salles Gilles, Michallet Anne Sophie, Hayette Sandrine, Sujobert Pierre

机构信息

Hospices Civils de Lyon, Service d'hématologie biologique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.

Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052 CNRS 5286, Equipe «Clinical and Experimental Models of Lymphomagenesis», Lyon, France.

出版信息

Leukemia. 2020 Aug;34(8):2257-2259. doi: 10.1038/s41375-020-0716-1. Epub 2020 Jan 29.

DOI:10.1038/s41375-020-0716-1

PMID:31996767

Abstract

摘要

相似文献

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.

Leukemia. 2020 Aug;34(8):2257-2259. doi: 10.1038/s41375-020-0716-1. Epub 2020 Jan 29.

Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.

Haematologica. 2014 Nov;99(11):e231-4. doi: 10.3324/haematol.2014.108365. Epub 2014 Jul 4.

Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.

Br J Haematol. 2007 Nov;139(3):507-9. doi: 10.1111/j.1365-2141.2007.06805.x. Epub 2007 Sep 14.

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia.

Leukemia. 2007 Jan;21(1):1-3. doi: 10.1038/sj.leu.2404457.

Another step forward in the 20-year history of mutations in chronic lymphocytic leukemia.

Haematologica. 2019 Feb;104(2):219-221. doi: 10.3324/haematol.2018.207399.

A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.

Br J Haematol. 2021 Feb;192(3):e77-e81. doi: 10.1111/bjh.17257. Epub 2020 Dec 5.

Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.

Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):252-60. doi: 10.1016/j.clml.2012.03.005. Epub 2012 May 4.

Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia.

Leuk Lymphoma. 2018 May;59(5):1239-1243. doi: 10.1080/10428194.2017.1370549. Epub 2017 Sep 3.

Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells.

Mol Med. 2011;17(11-12):1188-95. doi: 10.2119/molmed.2011.00104. Epub 2011 Jul 13.

Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.

Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):678-685.e4. doi: 10.1016/j.clml.2019.03.002. Epub 2019 Mar 11.

引用本文的文献

IGHV Mutational Status in a Cohort of Bulgarian CLL Patients: High Unmutated CLL Prevalence in North-East Bulgaria.

Balkan J Med Genet. 2024 Sep 6;27(1):15-19. doi: 10.2478/bjmg-2024-0003. eCollection 2024 Jun.

Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia.

Sci Rep. 2021 Sep 3;11(1):17668. doi: 10.1038/s41598-021-97198-3.

本文引用的文献

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.

N Engl J Med. 2019 Aug 1;381(5):432-443. doi: 10.1056/NEJMoa1817073.

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations.

Leukemia. 2017 Jul;31(7):1477-1481. doi: 10.1038/leu.2017.125. Epub 2017 Apr 25.

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia.

Leukemia. 2007 Jan;21(1):1-3. doi: 10.1038/sj.leu.2404457.

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Leukemia. 2003 Dec;17(12):2257-317. doi: 10.1038/sj.leu.2403202.

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Blood. 1999 Sep 15;94(6):1848-54.

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Blood. 1999 Sep 15;94(6):1840-7.

Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire.

Mol Immunol. 1992 Feb;29(2):193-203. doi: 10.1016/0161-5890(92)90100-c.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献